Non-invasive tests for evaluating treatment response in NAFLD

J Hepatol. 2023 Mar;78(3):e101-e102. doi: 10.1016/j.jhep.2022.08.015. Epub 2022 Aug 23.

Authors

Heike Bantel¹, Klaus Schulze-Osthoff²

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany. Electronic address: Bantel.Heike@mh-hannover.de.
² Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.

PMID: 36007707
DOI: 10.1016/j.jhep.2022.08.015

No abstract available

Keywords: Cytokeratin-18; Liver fibrosis; NAFLD; NASH; Non-invasive test.

Publication types

Letter
Comment

MeSH terms

Humans
Liver Cirrhosis
Non-alcoholic Fatty Liver Disease*